Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-25-000883
Filing Date
2025-03-26
Accepted
2025-03-26 14:30:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 dfan14a09076068_03262025.htm DFAN14A 36876
  Complete submission text file 0000921895-25-000883.txt   38218
Mailing Address 2727 KIRBY DRIVE UNIT 29L HOUSTON TX 77098
Business Address
Radoff Bradley Louis (Filed by) CIK: 0001380585 (see all company filings)

Type: DFAN14A

Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Subject) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-39661 | Film No.: 25772281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)